4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
DiaMedica Therapeutics Inc. (DMAC) operates in the Biotechnology industry and is headquartered in Minneapolis, United States with about 35 employees. Its market capitalization is roughly $412 million. In the fiscal year ended 2025-12-31, DMAC reported $0M in revenue and ($33M) in net income.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($34M) | ($27M) | ($21M) | ($14M) |
| Net Income | ($33M) | ($24M) | ($19M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($10M) | ($9M) | ($9M) | ($8M) | ($8M) |
| Net Income | ($10M) | ($9M) | ($9M) | ($8M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $61M | $46M | $54M | $34M | — |
| Total Liabilities | $5M | $6M | $3M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DMAC viewer.
About TickerBase · Data methodology & sources